|
WBP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.008100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28709999999999E-06 |
| Normal-vs-Stage2 |
8.380800E-03 |
| Normal-vs-Stage3 |
7.994400E-01 |
| Normal-vs-Stage4 |
7.816400E-03 |
| Stage1-vs-Stage2 |
5.833800E-01 |
| Stage1-vs-Stage3 |
1.196430E-02 |
| Stage1-vs-Stage4 |
8.151800E-01 |
| Stage2-vs-Stage3 |
5.527900E-02 |
| Stage2-vs-Stage4 |
8.774400E-01 |
| Stage3-vs-Stage4 |
3.619600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.34239999999231E-05 |
| Normal-vs-AfricanAmerican |
9.220100E-03 |
| Normal-vs-Asian |
9.828200E-01 |
| Caucasian-vs-AfricanAmerican |
3.743200E-01 |
| Caucasian-vs-Asian |
7.049700E-02 |
| AfricanAmerican-vs-Asian |
2.963600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82309999985364E-07 |
| Normal-vs-Female |
3.140000E-01 |
| Male-vs-Female |
4.08490000000095E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.275580E-02 |
| Normal-vs-Extreme_Weight |
3.74739999999818E-05 |
| Normal-vs-Obese |
2.915700E-03 |
| Normal-vs-Extreme_Obese |
8.783400E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.144600E-01 |
| Normal_Weight-vs-Obese |
8.864800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.983600E-01 |
| Extreme_Weight-vs-Obese |
1.870380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.136400E-01 |
| Obese-vs-Extreme_Obese |
5.752200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.520000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.457400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.18340000002204E-06 |
| Normal-vs-Age(81-100Yrs) |
3.884800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.473840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.918900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.918300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.493640E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.801600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.042800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.21980031315184E-10 |
| Normal-VS-Type2 PRCC |
2.939800E-02 |
| Normal-VS-KIRP CIMP |
7.608800E-01 |
| Normal-VS-Unclassified PRCC |
3.856600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.384200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.612000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.079600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.882200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.131200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.515600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.863800E-03 |
| Normal-vs-N1 |
9.961800E-01 |
| Normal-vs-N2 |
5.008800E-01 |
| N0-vs-N1 |
3.371900E-02 |
| N0-vs-N2 |
4.853600E-01 |
| N1-vs-N2 |
4.532000E-01 |
|
|
